Formulary Coverage of Brand-Name Adalimumab and Biosimilars Across Medicare Part D Plans.Matthew J. Klebanoff,Pengxiang Li,John K. Lin,Jalpa A. DoshiJAMA（2024）引用 1|浏览4AI 理解论文溯源树样例生成溯源树，研究论文发展脉络Chat Paper正在生成论文摘要
